Rallybio Corp (RLYB) — Strategic Asset Allocation Index
Rallybio Corp (RLYB) has a Strategic Asset Allocation Index of 1.4% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $626.00K) total $626.00K, measured against net assets of $45.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check RLYB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Rallybio Corp Strategic Asset Allocation Index (2019–2024)
This chart shows how Rallybio Corp's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 1.4%, representing strategic assets of $626.00K against net assets of $45.96 Million USD. See RLYB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Rallybio Corp (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Rallybio Corp from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see RLYB stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $61.65 Million | ▼ -0.2 pp |
| 2023 | 0.2% | $239.00K | $- | $239.00K | $106.18 Million | ▼ 0.0 pp |
| 2022 | 0.2% | $415.00K | $385.00K | $30.00K | $169.32 Million | ▼ -0.5 pp |
| 2021 | 0.7% | $1.32 Million | $511.00K | $805.00K | $175.60 Million | ▲ +0.3 pp |
| 2020 | 0.4% | $597.00K | $287.00K | $310.00K | $136.00 Million | ▼ -3.6 pp |
| 2019 | 4.1% | $687.00K | $199.00K | $488.00K | $16.86 Million | — |